ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+9.8%
5Y CAGR+19.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+9.8%/yr
vs +65.5%/yr prior
5Y CAGR
+19.8%/yr
Recent deceleration
Acceleration
-55.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $33.19M | +15.1% |
| 2024 | $28.82M | +12.6% |
| 2023 | $25.61M | +2.1% |
| 2022 | $25.09M | +14.0% |
| 2021 | $22.01M | +64.0% |
| 2020 | $13.42M | +184.1% |
| 2019 | $4.72M | +41.3% |
| 2018 | $3.35M | +33.0% |
| 2017 | $2.52M | - |